These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2518327)

  • 1. Fatal encephalopathy with ifosfamide/mesna.
    Verdeguer A; Castel V; Esquembre C; Ferris J; Fernandez JM; Ruiz JG
    Pediatr Hematol Oncol; 1989; 6(4):383-5. PubMed ID: 2518327
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible encephalopathy with ifosfamide/mesna.
    Salloum E; Flamant F; Ghosn M; Taleb N; Akatchereian C
    J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
    [No Abstract]   [Full Text] [Related]  

  • 3. Encephalopathy with rapid infusion ifosfamide/mesna.
    Perren TJ; Turner RC; Smith IE
    Lancet; 1987 Feb; 1(8529):390-1. PubMed ID: 2880199
    [No Abstract]   [Full Text] [Related]  

  • 4. [Encephalopathy caused by an ifosfamide-mesna combination].
    Beuzeboc P; Dorval T; Garcia-Giralt E; Jouve M; Livartowski A; Palangie T; Scholl S; Pouillart P
    Presse Med; 1988 Apr; 17(12):591-2. PubMed ID: 2967486
    [No Abstract]   [Full Text] [Related]  

  • 5. Avoiding ifosfamide/mesna encephalopathy.
    Meanwell CA; Kelly KA; Blackledge G
    Lancet; 1986 Aug; 2(8503):406. PubMed ID: 2874408
    [No Abstract]   [Full Text] [Related]  

  • 6. Ifosfamide, mesna, and encephalopathy.
    Lancet; 1985 Jun; 1(8442):1398-9. PubMed ID: 2861351
    [No Abstract]   [Full Text] [Related]  

  • 7. Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
    Ghosn M; Carde P; Leclerq B; Flamant F; Friedman S; Droz JP; Hayat M
    Bull Cancer; 1988; 75(4):391-2. PubMed ID: 3132998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalopathy associated with ifosphamide/mesna therapy.
    Meanwell CA; Blake AE; Latief TN; Blackledge G; Mould JJ; Blake DR; Shaw IC; Honigsberger L; Spooner D; Williams AC
    Lancet; 1985 Feb; 1(8425):406-7. PubMed ID: 2857462
    [No Abstract]   [Full Text] [Related]  

  • 9. Ifosfamide/mesa and encephalopathy.
    Cantwell BM; Harris AL
    Lancet; 1985 Mar; 1(8431):752. PubMed ID: 2858016
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of ifosfamide/mesna associated encephalopathy.
    Meanwell CA; Blake AE; Kelly KA; Honigsberger L; Blackledge G
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):815-9. PubMed ID: 3095121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
    Husband DJ; Watkin SW
    Lancet; 1988 May; 1(8594):1116. PubMed ID: 2896952
    [No Abstract]   [Full Text] [Related]  

  • 12. Ifosfamide and mesna.
    Schoenike SE; Dana WJ
    Clin Pharm; 1990 Mar; 9(3):179-91. PubMed ID: 2107997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide/mesna encephalopathy.
    McCallum AK
    Lancet; 1987 Apr; 1(8539):987. PubMed ID: 2882385
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
    Fosså SD; Talle K
    Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant pleural mesothelioma: phase II pilot study of ifosfamide and mesna.
    Alberts AS; Falkson G; Van Zyl L
    J Natl Cancer Inst; 1988 Jul; 80(9):698-700. PubMed ID: 3131539
    [No Abstract]   [Full Text] [Related]  

  • 16. Ifosfamide/mesna and hematuria.
    Pratt CB; Goren MP
    Cancer Treat Rep; 1987 Nov; 71(11):1124-5. PubMed ID: 3119210
    [No Abstract]   [Full Text] [Related]  

  • 17. Nursing implications in the administration of ifosfamide and mesna.
    Richters JE
    Oncol Nurs Forum; 1990; 17(2):276. PubMed ID: 2107534
    [No Abstract]   [Full Text] [Related]  

  • 18. Ifosfamide and Mesna in advanced malignancies.
    Li GC; Brock N; Li JQ; Guan ZZ; He YJ
    Chin Med J (Engl); 1988 Mar; 101(3):213-20. PubMed ID: 3136996
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
    Iwasaku-Fujimoto M; Fujiwara F; Todo S; Morioka Y; Imashuku S
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):403-6. PubMed ID: 2106836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas.
    Ajani JA; Abbruzzese JL; Goudeau P; Faintuch JS; Yeomans AC; Boman BM; Nicaise C; Levin B
    J Clin Oncol; 1988 Nov; 6(11):1703-7. PubMed ID: 3141592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.